Terminal plasma half-life is the time required to divide the plasma concentration by two after reaching pseudo-equilibrium, and not the time required to eliminate half the administered dose. When the process of absorption is not a limiting factor, half-life is a hybrid parameter controlled by plasma clearance and extent of distribution. In contrast, when the process of absorption is a limiting factor, the terminal half-life reflects rate and extent of absorption and not the elimination process (flip-flop pharmacokinetics). The terminal half-life is especially relevant to multiple dosing regimens, because it controls the degree of drug accumulation, concentration fluctuations and the time taken to reach equilibrium.
Chat with our AI personalities
Terminal half-life is the time it takes for the concentration of a drug in the body to decrease by half during the elimination phase, after reaching steady state. It is used to estimate how long a drug will stay in the body once the dosing is stopped. Terminal half-life is influenced by factors such as drug metabolism and elimination rate.
c.half-life
The half-life of promethium-145 is approximately 17.7 years. Promethium-147 has a half-life of about 2.62 years.
The length of time for the second half-life is the same as the first half-life. Each half-life represents the time it takes for half of the radioactive atoms in a sample to decay. This process continues exponentially with each subsequent half-life.
Half-life is described in time units.
Planet Half-Life was created in 1999.